1305170-07-3

Upstream product

• 933786-79-9 (4-{[4-(trifluoromethyl)phenyl]oxy}phenyl)methanol 
• 1128268-02-9 ethyl 1-[6-(2-hydroxylphenyl)pyridine-2-yl]-5-trifluoromethyl-1H-pyrazole-4-carboxylate 

Downstream Products

• 1128256-55-2 5-(Trifluoromethyl)-1-{6-[2-({4-[4-(trifluoromethyl)phenoxy]benzyl}oxy)phenyl]pyridin-2-yl}-1H-pyrazole-4-carboxylic acid 

Relevant academic research and scientific papers

SOLUBLE GUANYLATE CYCLASE ACTIVATORS

A compound having the structure useful for treatment or prevention of cardiovascular diseases, endothelial dysfunction, diastolic dysfunction, atherosclerosis, hypertension, angina pectoris, thromboses, restenoses, myocardial infarction, strokes, cardiac insufficiency, pulmonary hypertonia, erectile dysfunction, asthma bronchiale, chronic kidney insufficiency, diabetes, or cirrhosis of the liver in a human or animal patient.